GRFS (GRFS) Stock Price & Analysis
GRFS (GRFS) fell 1.01% to USD 7.8 as of September 8, 2026 at 05:46 UTC, according to Nexqual real-time market data.
GRFS last closed at USD 7.8; the session ranged USD 7.78–7.84 on volume of 157,911 shares. Market capitalization is —, with a 52-week range of USD 6.96–10.23 (NMS). Source: Nexqual, September 8, 2026 at 05:46 UTC.
Key Statistics (as of September 8, 2026 at 05:46 UTC)
| Price | USD 7.8 |
|---|---|
| Change | ▼ 1.01% (down) |
| Previous Close | USD 7.8 |
| Open | USD 7.8 |
| Day Range | USD 7.78 – 7.84 |
| 52-Week Range | USD 6.96 – 10.23 |
| Volume | 157,911 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (GRFS)
Nexqual's technical model rates GRFS "NEUTRAL" based on 3 bullish and 2 bearish signals across 128 daily candles, as of September 8, 2026 at 05:46 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 48.47 (neutral) |
| vs SMA50 | Above (USD 7.68) |
| MACD | 0.01 (positive) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| HCM | HUTCHMED (China) Limited | USD 14.09 | ▲ 17.03% |
| LIVN | LivaNova PLC | USD 81.92 | ▼ 0.58% |
| IRWD | Ironwood Pharmaceuticals, Inc. | USD 4.26 | ▼ 3.4% |
| LKFT | Lakefront Biotherapeutics | USD 28.49 | ▼ 1.11% |
| FMS | Fresenius Medical Care AG | USD 22.66 | ▲ 0.04% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 05:46 UTC. This page is informational and not investment advice.